Vaxcyte, Inc. PCVX
56.21
(0.69)
(1.21%)
as of 25 Sep
- Market cap
- $8.5B
- P/E
- 0.0×
Follow PCVX
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
— | 9.93 | 5.58 | 8.30 | 8.93 | 23.26 | 7.54 | 12.75 | 7.91 |
Net Debt/EBITDA |
— | 1.92 | 1.11 | 4.38 | 2.49 | 4.16 | 2.19 | 2.95 | 1.71 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
— | 1.03 | 0.94 | 0.52 | 1.21 | 0.76 | 0.74 | 0.98 | 0.86 |
Capex/Depreciation |
— | (1.71) | (0.97) | (0.79) | (1.34) | (0.69) | 0.65 | 0.98 | (1.32) |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 35.94% | 61.27% | (74.51%) | (31.78%) | (36.11%) | (36.67%) | (20.41%) | (25.59%) | |
| — | (83.29%) | (73.66%) | (38.91%) | (27.91%) | (33.59%) | (33.33%) | (18.86%) | (23.54%) | |
ROIC |
— | 0.00% | 0.00% | 0.00% | (170.29%) | (652.79%) | (182.55%) | (22.84%) | (51.34%) |
Return on Tangible Assets |
— | (46.53%) | (92.99%) | (25.83%) | (42.48%) | (24.49%) | (39.05%) | (25.13%) | (45.66%) |
Average Days of Receivables |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
— | (8.88) | (12.74) | (1.62) | (2.46) | (2.72) | (3.22) | (3.89) | (4.92) |
Cash per Share |
— | 18.21 | 15.54 | 13.07 | 4.74 | 14.36 | 11.12 | 14.32 | 11.47 |
Shareholders Equity per Share |
— | 16.55 | 14.21 | 11.71 | 5.47 | 14.70 | 12.77 | 27.10 | 19.73 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 16.55 | 14.21 | 11.71 | 5.47 | 14.70 | 12.77 | 27.10 | 19.73 |
Free Cash Flow |
— | (32.24) | (48.34) | (47.73) | (127.92) | (176.44) | (312.85) | (475.05) | (669.29) |
Working Capital |
— | 59.96 | 50.67 | 342.14 | 227.63 | 902.03 | 950.62 | 1,647.81 | 1,421.61 |
Capital Expenditures |
— | (1.77) | (1.19) | (1.10) | (6.53) | (5.84) | (16.06) | (22.43) | (13.71) |
Net Current Asset Value |
— | 55.95 | 49.96 | 342.02 | 216.03 | 889.99 | 928.51 | 1,582.49 | 1,310.15 |
| Other line items | |||||||||
Quick Ratio |
— | 9.85 | 5.34 | 8.24 | 8.57 | 22.98 | 7.43 | 12.46 | 7.59 |
Depreciation/Fixed assets |
— | 0.30 | 0.36 | 0.43 | 0.61 | 0.82 | (0.31) | (0.12) | 0.04 |
Cash ROIC |
— | (26.85%) | (44.76%) | (6.82%) | (24.41%) | (9.60%) | (16.22%) | (12.88%) | (21.50%) |
Accounts Receivable Turnover |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Revenue per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
— | (8.39) | (12.42) | (1.58) | (2.34) | (2.63) | (3.05) | (3.71) | (4.82) |
Capex per Share |
— | (0.49) | (0.31) | (0.04) | (0.13) | (0.09) | (0.17) | (0.18) | (0.10) |
Average Receivables |
— | — | 0.25 | 0.00 | 0.50 | 1.00 | — | — | — |
Average Payables |
— | 3.10 | 3.10 | 16.58 | 18.27 | 8.28 | 12.19 | 31.52 | 59.68 |
Average Assets |
— | 35.40 | 68.25 | 229.26 | 358.58 | 665.26 | 1,207.05 | 2,459.62 | 3,257.02 |
Average Common Equity |
— | (82.05) | (82.05) | 119.74 | 314.93 | 618.82 | 1,097.04 | 2,273.14 | 2,995.66 |
Capex to Sales |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates